Under the terms of the agreement Mellow Hope will be fully authorized to do the International marketing of Haemophilus influenza type “B” conjugate vaccine in the global market. Safe Harbor Statement Information in this filing may contain statements about future expectations, plans, prospects or performance of Hard to Treat Diseases, Inc. that constitute forward-looking statements … Read Full Press Release
NEW YORK, Dec. 2 /PRNewswire/ — Reportlinker.com announces that a new market research report is available in its catalogue: Blood glucose levels or blood sugar levels represent the measurement, which indicates whether or not a person is suffering from diabetes. Blood glucose monitoring can be performed at home using a variety of blood monitoring products … Read Full Press Release
This report deals with transdermal drug delivery – an approach used to deliver drugs through the skin for therapeutic use as an alternative to oral,intravascular, subcutaneous and transmucosal routes. Various transdermal drug delivery technologies are described including the use of suitable formulations, carriers and penetration enhancers. The most commonly used transdermal system is the skin … Read Full Press Release
BioFlorida, Florida’s statewide trade association for the bioscience industry, announces its recent move to new offices shared with BioFlorida member Novak Druce + Quigg, an intellectual property law firm with a strong focus on the life science industry. “We’re excited to welcome Novak Druce + Quigg to the Florida bioscience market and for extending generous … Read Full Press Release
Additionally, this report also provides you the latest export situation of sugar alcohols, raw material supply for sugar alcohols, etc. Moreover, in 2011 version, the report will add the competition analysis between sugat alcohols and high intensity sweeteners. This report combines CCM’s expertise in sugar alcohols market research. Highlights of this report are as follows: … Read Full Press Release
Jefferies & Company, Inc., Piper Jaffray & Co. and Cowen and Company, LLC are acting as joint book-running managers for the offering. Concurrently with the public offering described above, MannKind intends to issue to The Mann Group LLC, an entity controlled by MannKind’s chief executive officer and principal stockholder, Alfred E. Mann, restricted shares of … Read Full Press Release
The Market Intelligence report provides critical market data for Spain patient monitoring and diagnostics market and its product categories. The data includes market size in terms of value and volume; average selling price for each product type, growth trends and market shares of companies at sector and category level. It’s vital cross category comparison and … Read Full Press Release
ProNAi Therapeutics, Inc., a developer of novel nucleic acid therapeutics, announces the appointment Nick Glover, Ph.D. as President and Chief Executive Officer. The company’s previous CEO, Mina Sooch, will be leaving the organization to pursue new opportunities. On behalf of ProNAi’s board, Chairman Donald Parfet said, “The Company’s organization has reached a critical juncture. We … Read Full Press Release
– Pharma and biotech industry stock market indices have outperformed those of other industries in the study period. – Profitability is reducing in large pharmaceuticals companies. – Patent expiry and revenue loss in pharma and biotech companies. – Government efforts to contain drug prices. – Increasing market demand for drugs. – Declining research & development … Read Full Press Release
Several factors are driving global acute lymphocytic leukemia therapeutics market growth including presence of high unmet needs for appropriate drugs while current treatment options cannot cure the disease completely and hence the demand remains high. Therefore, drugs that can cause disease remission in patients are expected to drive the growth of the market. The rise … Read Full Press Release
“Over the last few years we presented our members with many exciting opportunities,” said Yaniv Sneor, a MABA co-founder and president of Blue Cactus Consulting, “However, our current process has resulted in only a few investments. While high selectivity is not unusual among our peers in the early stage biotech angel and venture capital communities, … Read Full Press Release
Generex Biotechnology Corporation (OTCPink:GNBT) today announced a reverse stock split of its shares of common stock at a ratio of 1-for-1000. As of the open of the market on March 14, 2017, the Company’s common stock will begin trading on a split-adjusted basis. Generex President & Chief Executive Officer Joseph Moscato provided the following commentary … Read Full Press Release
Legislation designed to grow Illinois’ bio-based economy has been introduced by Senator Andy Manar (D-Bunker Hill) and Senator Chapin Rose (R-Mahomet). Senate Bill 1656 provides incentives to Illinois businesses to produce and sell new renewable products made from biomass and other renewable sources. The legislation builds upon Illinois’ strong agricultural base and seeks to provide … Read Full Press Release
Active-Investors.com is focused on giving you timely information and the inside line on companies that matter to you. This morning, Alnylam Pharma most recent news is on our radar and we have decided to include it on our blog post. Today’s free coverage ALNY and SNY is available at: The Phase-II and Phase-III clinical testing … Read Full Press Release
“Receiving this honor for the fifth time validates the great culture our team has created at Veracyte,” said Bonnie Anderson, Veracyte’s chairman and chief executive officer. “We work very hard to ensure every one of our employees understands our mission to improve patient care and their absolute importance in helping us achieve it. This prestigious … Read Full Press Release
At least 660,593,556 Shares to be issued to SalvaRx Group plc. will be immediately distributed to its shareholders in the ratio of 18 consideration Portage shares for each SalvaRx share held. Following the investment in iOx, the directors evaluated several other business opportunities. After some initial due diligence, these opportunities were not pursued further. This … Read Full Press Release
Lonza is one of the world’s leading suppliers to the pharmaceutical, healthcare, and life science industries. Its products and services span its customers’ needs from research to final product manufacture. Lonza is the global leader in the production and support of active pharmaceutical ingredients both chemically as well as biotechnologically. Biopharmaceuticals are one of the … Read Full Press Release
Over the last decade pharmaceutical and biotechnology companies have entered a period where they have become confronted by a variety of complex issues affecting their operational efficiency and profitability. It has now become generally acknowledged that the current business models have become both economically unsustainable and operationally unsuited to act quickly enough to produce the … Read Full Press Release
In a blind test in collaboration with a leading pharmaceutical company, the RNAscope(TM) FFPE assay demonstrated PCR-level sensitivity and specificity, detecting an RNA biomarker in all samples deemed positive by real time RT-PCR but not in samples deemed negative. In contrast, using a traditional non-isotopic ISH, the collaborator detected the biomarker only in the highest … Read Full Press Release
Highlights: Strong operational performance driven by Discovery Alliance Business (DAB) Evotec’s revenues for the first quarter 2009 were EUR 8.2 million, up 13% from last year’s level (2008: EUR 7.3 million). This is mainly the result of strong underlying revenues from our discovery alliances business, higher income from licenses as well as a portion of … Read Full Press Release
UC is a chronic inflammatory bowel disease (IBD) of the colon. It is estimated that 1.4 million Americans have IBD with the number evenly split between UC and Crohn’s disease. An estimated 150,000 children under age 17 are living with debilitating symptoms of IBD.(1) A total of 60 patients with moderately to severely active UC … Read Full Press Release
During testing, veterinarians found 92% of dogs receiving StrixNB showed a significant improvement in their dental and oral hygiene including the freshening of breath. The Company will continue to work with veterinarians on an ongoing basis to build additional case study profiles and market information. “StrixNB has proven to be an effective oral care product … Read Full Press Release
The company reported total revenue of $6.9 million for the nine months ending September 30, 2013, an increase of 41% over the nine months ended September 30, 2012. The company is a Los Angeles-based biotechnology company that develops and commercializes nutrient-based and pharmaceutical therapeutic systems. Its patented prescription medical food products for the treatment of … Read Full Press Release
The primary objectives of the trial are to estimate the progression-free survival hazard ratio of the combination of weekly paclitaxel with REOLYSIN to weekly paclitaxel alone in patients with persistent or recurrent ovarian, fallopian tube, or primary peritoneal cancer and to determine the frequency and severity of adverse events associated with treatment with weekly paclitaxel … Read Full Press Release
PMCB has achieved developmental progress over the past year and the launch of a series of clinical trials in 2015 should raise the company’s profile. These milestones include mid-stage and preclinical studies for the treatment of pancreatic cancer and its serious and debilitating symptoms, and for diabetes. An analyst brief which covers a brief analysis … Read Full Press Release
“James has a strong, diverse corporate practice and will be a great addition to the firm. His considerable knowledge and expertise in M&A, emerging growth and private equity makes him a significant asset for the firm and our clients,” said Jon W. Newby, vice chairman of Sheppard Mullin. “I am excited to join Sheppard Mullin. … Read Full Press Release
Stock Callers (SC) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. SC has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on … Read Full Press Release
Patients were eligible to enroll in OSLER-1 study after completing one of the double-blind Phase 2 parent studies without experiencing a serious AE requiring treatment discontinuation. During the first year patients were randomized 2:1 to Repatha 420 mg monthly in addition to SOC or SOC alone. After year one, all patients continuing in the study … Read Full Press Release
Neil Flanzraich, JD, Chief Business Officer, Alzheon, Inc. (Photo: Business Wire) “I am delighted to welcome such an accomplished executive as Neil to the Alzheon team,” said Martin Tolar, MD, PhD, Founder, President and Chief Executive Officer of Alzheon. “Neil is an entrepreneur and investor with an exceptional track record driving business and financing strategies, … Read Full Press Release
These young analysts spoke optimistically about the current bull market, now in its 10th year of record gains. They’re not worried about a correction or downturn anytime soon, despite what some of their older peers are predicting. You can see the full list of finalists here. Here’s more on three of the candidates’ top sectors, … Read Full Press Release